Adamas Biotech develops nutraceutical-based prophylactic and therapeutic solutions for clinical and wellness indications.
Adamas Biotech has raised $453K in total funding. The most recent round was Grant. The last funding was announced in August 2024.
Adamas Biotech's investors include Banco BPM, Cube Labs, Istituto Nazionale Biostrutture e Biosistemi, National Biodiversity Future Center.
Adamas Biotech is headquartered in Lecce, Italy.
Adamas Biotech develops nutraceutical-based prophylactic and therapeutic solutions for clinical and wellness indications.
Adamas Biotech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adamas Biotech — Funding & Investors." VCBacked, August 26, 2024, https://www.vcbacked.co/company/adamas-biotech. Accessed August 14, 2026.
VCBacked. (2024). Adamas Biotech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/adamas-biotech
{{cite web |title=Adamas Biotech — Funding & Investors |url=https://www.vcbacked.co/company/adamas-biotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated